# PAVmed (PAVM) — Earnings

PAVM · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/pavm/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.47 |
| EPS estimate | −$0.47 |
| EPS surprise | +0.00% |
| Revenue surprise | +0.00% |
| Revenue | $48,000.00 |
| Revenue estimate | $48,000.00 |
| Reported | Aug 13, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1624326/000143774926027733/pavm20260630_10q.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/3e166d6a-1686-d8ed-00fa-0bbba27abe7a.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 13, 2026 | −$0.47 | −$0.47 | 0.00% | $48,000.00 | $48,000.00 |
| Q1 2026 | May 14, 2026 | −$0.70 | −$4.42 | -531.43% | $74,000.00 | $22,000.00 |
| Q4 2025 | Mar 27, 2026 | −$5.40 | −$2.05 | 62.04% | — | $52,000.00 |
| Q3 2025 | Nov 12, 2025 | −$5.10 | −$8.70 | -70.59% | $12,500.00 | $5,000.00 |
| Q2 2025 | Aug 14, 2025 | −$3.90 | −$22.20 | -469.23% | $10,000.00 | $6,000.00 |
| Q1 2025 | May 15, 2025 | −$10.50 | $10.20 | 197.14% | $10,000.00 | $8,000.00 |
| Q4 2024 | Mar 24, 2025 | −$3.30 | $3.97 | 220.24% | $20,000.00 | $10,000.00 |
| Q3 2024 | Nov 14, 2024 | $59.25 | $193.10 | 225.91% | $1.1M | $996,000.00 |
| Q2 2024 | Aug 12, 2024 | −$43.60 | −$35.70 | 18.12% | $1.2M | $979,000.00 |
| Q1 2024 | May 13, 2024 | −$50.20 | −$78.60 | -56.57% | $1.1M | $1.0M |
| Q4 2023 | Mar 25, 2024 | −$48.89 | −$59.40 | -21.49% | $1.0M | $1.0M |
| Q1 2023 | May 15, 2023 | −$80.16 | −$73.69 | 8.06% | $225,000.00 | $446,000.00 |
| Q1 2022 | May 12, 2022 | −$78.87 | −$77.57 | 1.64% | $225,000.00 | $189,000.00 |
| Q4 2021 | Mar 29, 2022 | −$62.06 | −$77.57 | -25.00% | $462,500.00 | $300,000.00 |
| Q2 2021 | Aug 12, 2021 | −$38.79 | −$54.30 | -40.00% | $126,667.00 | — |
| Q1 2021 | May 17, 2021 | −$46.54 | −$50.42 | -8.33% | $25,000.00 | — |

## Frequently Asked Questions

### When did PAVmed (PAVM) last report earnings?

PAVmed last reported on Aug 13, 2026, covering fiscal Q2 2026.

### Did PAVM beat earnings estimates?

PAVmed reported EPS of −$0.47 for Q2 2026, in line with the −$0.47 consensus estimate.

### How much revenue did PAVM report last quarter?

PAVmed reported $48,000.00 in revenue for Q2 2026, against a consensus estimate of $48,000.00.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).